A A A Print


The Georgetown-Howard Universities Center for Clinical and Translational Science, or “GHUCCTS”, welcomes you to look at each of our programs and what we offer. We represent a unique consortium of academic and medical institutions across the greater Washington DC area, as described under our “Member Institutions”. The formation of GHUCCTS was inspired by the National Center for Research Resources (NCRR) Clinical and Translation Science Award (CTSA) initiative to improve how academic medical centers perform clinical research and translational science. This initiative will empower researchers to develop new treatments and cures for diseases more quickly, and to make them available to our patients and our communities more efficiently. The Georgetown-Howard Universities Center for Clinical and Translational Science was funded by NCRR on July 1, 2010, thereby becoming one of just 55 CTSA-funded centers in the U.S.


GHUCCTS was founded on the CTSA philosophy of interdisciplinary communication and exchange that encourages partnerships and collaborations amongst organizations (academic, government and industry) involved with health care across our geographic region, as well as across our nation. Through multiple partnerships and collaborations, GHUCCTS is committed to transforming clinical and translational research by facilitating the adoption of new scientific advances into improvements in health care, particularly to underserved groups in our communities, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.


The Georgetown-Howard University Center for Clinical and Translational Science has two PIs with complementary expertise who share leadership of the consortium. The PIs were charged by the GHUCCTS Steering Committee with developing the GHUCCTS consortium and the CTSA application. We have worked together intensively and productively, providing leadership and guidance to the overall consortium and to the workgroups that were established to address each of the many areas required for successful clinical and translational research and education. We have established this public website to promote community education and engagement in GHUCCTS activities. In the near future, we will complete our “Find Clinical Trials” page, where interested individuals can search for ongoing GHUCCTS research in specific diseases in order to obtain more information about our research programs. Please continue to visit our site for this and more information about GHUCCTS educational and research activities.

Citing GHUCCTS in Publication

If you receive funding or services from GHUCCTS Components (Programs), please remember to cite GHUCCTS in your publication. Use the navigation on the left side "Citing GHUCCTS" to submit the infomation directly to GHUCCTS.

GHUCCTS supports consultative resources, facilities and funding opportunities related to clinical and translational research.

GHUCCTS is a multi-institutional consortium of medical research institutions forged from a desire to promote clinical research and translational science. The members of the GHUCCTS consortium are: Georgetown University (GU), Howard University (HU), MedStar Health Research Institute (MHRI), Oak Ridge National Laboratory (ORNL), and the Washington Veteran’s Affairs Medical Center (VAMC).

Through multiple partnerships and collaborations among the member institutions, GHUCCTS will transform clinical research and translational science in order to bring new scientific advances to health care.

To achieve this mission, GHUCCTS announces Request For Applications (RFAs) to support innovative and collaborative research, and help investigators find opportunities to address their scientific questions and projects. Each RFA below has a unique description and outlines the type of programs that are eligible, the expectations and how to submit an application. Once approved, GHUCCTS will provide access to a wealth of advisors, collaborators and resources to enable applicants to innovate and to transform their own environment to develop and advance clinical and translational science.


RFA Announcements:

Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness (R01)
This funding opportunity seeks to update the randomized control trial (RCT) design using novel research methods that are practical, innovative, and hold promise for producing more effective outcomes.  Novel clinical research designs, applied to symptom management trials, may identify those treatment strategies that best alter the course of symptom burden in chronic illness by addressing the issues of varied treatment responses across patients, subject retention, and adherence to treatment regimens.

Pilot and Collaborative Studies Funding Opportunity
The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the availability of support for pilot and collaborative studies. The mission of GHUCCTS and the national Clinical Translational Science Award (CTSA) programs includes promotion of interdisciplinary research that will translate basic findings into clinical applications and clinical research findings into community use in order to improve human health.

R03 Opportunity: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health-Related Research

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Translational Technologies Resources (TTR) Component Request for Applications
The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), Translational Technologies Resources component (TTR) is pleased to announce the availability of funding to support the use of existing TTR resources to generate preliminary data for grant submission, development of novel technologies or approaches for basic or clinical research.